Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia, Myeloid, Chronic-Phase 7Breast Neoplasms 6Leukemia 5Blast Crisis 4Philadelphia Chromosome 3Neoplasms 3Bronchiolitis Obliterans Syndrome 3Neoplasm Metastasis 2Leukemia, Myeloid, Accelerated Phase 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Translocation, Genetic 1Thymus Neoplasms 1Thymoma 1Pathologic Processes 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Myeloproliferative Disorders 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Hematologic Diseases 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Diseases 1Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

bosutinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Breast Cancer (Parts 1 and 2) × bosutinib × Clear all
NCT00959946 2013-02-22

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Pfizer

Phase 1/2 Terminated
32 enrolled 15 charts
BreastCNSGastrointestinal

Advanced Breast Cancer (Parts 1 and 2)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡